Bruno Bouca
Overview
    Explore the profile of Bruno Bouca including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              8
            
            
              Citations
              27
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Manique I, Amaral S, Matias A, Bouca B, Serranito S, Torres J, et al.
  
  
    Int J Endocrinol
    . 2023 Dec;
          2023:5563881.
    
    PMID: 38156095
  
  
          Introduction: Primary aldosteronism is the most common cause of secondary hypertension. Adrenal vein sampling is the gold standard for subtyping primary aldosteronism. However, this procedure is technically challenging and often...
      
2.
        
    
    Bouca B, Cascao M, Fiuza P, Amaral S, Bogalho P, Silva-Nunes J
  
  
    Endocrinol Diabetes Metab Case Rep
    . 2023 May;
          2023(2).
    
    PMID: 37199305
  
  
          Summary: 17-Alpha-hydroxylase deficiency (17OHD) is a rare autosomal recessive disease, representing 1% of cases of congenital adrenal hyperplasia. A 44-year-old female presented to the emergency department complaining of generalized asthenia...
      
3.
        
    
    Amaral S, Matias A, Bouca B, Manique I, Palha A, Cortez L, et al.
  
  
    Clin Case Rep
    . 2022 Dec;
          10(12):e6601.
    
    PMID: 36518913
  
  
          Pituitary metastases are rare. Clinical presentation could range from asymptomatic to panhypopituitarism or local symptoms. We present a case report of a 43-year-old male patient with a new onset headache,...
      
4.
        
    
    Manique I, Abegao Matias A, Bouca B, Rego T, Cortez L, Sabino T, et al.
  
  
    Metabolites
    . 2022 Nov;
          12(11).
    
    PMID: 36422255
  
  
          Diabetes mellitus (DM) has emerged as a major risk factor for COVID-19 severity and SARS-CoV-2 infection can worsen glycemic control and may precipitate new-onset diabetes. At-admission hyperglycemia (AH) is a...
      
5.
        
    Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report
  
  
    
    Bouca B, Roldao M, Bogalho P, Cerqueira L, Silva-Nunes J
  
  
    Front Endocrinol (Lausanne)
    . 2022 May;
          13:889074.
    
    PMID: 35600593
  
  
          Introduction: Cases of central diabetes insipidus (CDI) have been reported after COVID-19 infection, with hypophysitis being the most likely cause. COVID-19 vaccines potential adverse effects may mimetize some of these...
      
6.
        
    
    Bouca B, Bogalho P, Rizzo M, Silva-Nunes J
  
  
    Metabolites
    . 2022 Feb;
          12(2).
    
    PMID: 35208206
  
  
          Pheochromocytoma and paragangliomas (PPGL) are rare neuroendocrine tumors. In some patients they exhibit malignant behavior characterized by the presence of metastases, limiting treatment options and survival rates. Therapeutic options are...
      
7.
        
    
    Bouca B, Nogueira A, Caetano J, Cardoso R, Dinis I, Mirante A
  
  
    J Pediatr Endocrinol Metab
    . 2022 Feb;
          35(4):477-480.
    
    PMID: 35170268
  
  
          Objectives: Polyglandular autoimmune syndromes (PAS) are characterized by the association of two or more autoimmune diseases (AID) and are classified into four types. PAS type 1 is more frequently manifested...
      
8.
        
    
    Bouca B, Martins A, Bogalho P, Sousa L, Bilhim T, Gomes F, et al.
  
  
    Eur Thyroid J
    . 2022 Jan;
          11(1).
    
    PMID: 34981740
  
  
          Introduction: Amiodarone-induced thyrotoxicosis (AIT) can sometimes lead to life-threatening complications, especially in patients with congenital heart disease (CHD). We report the case of a patient with refractory AIT that was...